According to the FDA, nine ophthalmology drugs are in short supply.
They are:
1. Azithromycin (AzaSite) ophthalmic solution 1%
2, Cyclopentolate ophthalmic solution
3. Dexamethasone sodium phosphate injection
4. Echothiophate iodide (phospholine iodide) ophthalmic solution
5. Erythromycin ophthalmic ointment
6. Fluorescein Injection
7. Hydroxypropyl (Lacrisert) cellulose ophthalmic insert
8. Teprotumumab-trbw
9. Triamcinolone acetonide injectable suspension
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
